Five Prime Therapeutics IPO Research Information

Five Prime Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Five Prime Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Five Prime Therapeutics	FPRX - NASDAQ	$12.00-$14.00	$13.00	$16.00	2.8 million	9/18/2013
Underwriter(s): Jefferies, BMO Capital Markets, Wells Fargo Securities
Co-Manager(s): Guggenheim Securities
Industry: Health Care
Filing(s): Filed 2013-07-26 Terms Added 2013-09-04

Five Prime Therapeutics Quote & Chart - Click for current quote - FPRX

About Five Prime Therapeutics (adapted from Five Prime Therapeutics prospectus):
They are a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "FPRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.